Partnership powers integration across thousands of providers to prevent opioid abuse
The opioid epidemic requires innovative approaches, and the digital health industry is taking steps to make inroads against this crisis. Redox today announced that it is partnering with OpiSafe to expand the use of OpiSafe’s comprehensive pain medication management web and mobile platform to help thousands of providers across the country prescribe and treat pain more effectively while avoiding bad outcomes.
Redox integrates the OpiSafe platform with a provider’s electronic health record (EHR) to gather data needed to stratify risk for each patient on the basis of morphine equivalent dosing ranges, pain and function scores, opioid misuse risk scores, and automated Prescription Drug Monitoring Program (PDMP) checks. This data informs clinicians if a patient is at risk of opioid abuse before prescribing or during a treatment. Healthcare organizations can connect to Redox once and authorize the data they send and receive across the most extensive interoperable network in healthcare. OpiSafe offers thousands of healthcare providers, pharmacies, public health departments, first responders, and government agencies tools to manage opioid patients and overdose response.
Every day, more than 130 people in the United States die after overdosing on opioids. The Centers for Disease Control and Prevention estimates that the total “economic burden” of prescription opioid misuse alone in the United States is $78.5 billion a year, including the costs of healthcare, lost productivity, addiction treatment and criminal justice involvement.
“At OpiSafe, our mission is to deliver state-of-the-art clinical decision support to prescribers who consider prescribing opioids for pain or addiction,” said Chris Ennis, co-founder and CTO. “Connecting data available through PDMPs, urinalysis and analytics platforms to information stored in EHRs enables prescribers to make better decisions in less time. Redox and OpiSafe each embrace innovation as a means to better handle pain, reduce opioid misuse and ultimately improve outcomes for millions of Americans. Our partnership gives health systems the ability to rapidly deploy OpiSafe within dozens of EHR instances.”
“OpiSafe is placing premium value on developing and deploying innovative digital applications to meet the challenges of state and local opioid responses and the need for comprehensive frameworks for tackling substance abuse and behavioral health,” said Niko Skievaski, president and co-founder of Redox. “With OpiSafe in thousands of health facilities, impacting millions of patients every year, it’s critical that information flows freely and accurately. With the Redox hub in place, it will be easy for OpiSafe to build a network that unleashes a huge amount of data for providers and patients.”